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RESEARCH ARTICLE
LIF-dependent survival of embryonic stem cells is regulated by a
novel palmitoylated Gab1 signalling protein
Linda Sutherland1, Madeleine Ruhe1, Daniela Gattegno-Ho1, Karanjit Mann1,2, Jennifer Greaves2,
Magdalena Koscielniak1, Stephen Meek1, Zen Lu3,*, Martin Waterfall1, Ryan Taylor1, Anestis Tsakiridis4,
Helen Brown3, Sutherland K. Maciver5, Anagha Joshi1, Michael Clinton1, Luke H. Chamberlain2, Austin Smith6
and Tom Burdon1,‡
ABSTRACT
The cytokine leukaemia inhibitory factor (LIF) promotes self-renewal
of mouse embryonic stem cells (ESCs) through activation of the
transcription factor Stat3. However, the contribution of other ancillary
pathways stimulated by LIF in ESCs, such as the MAPK and PI3K
pathways, is less well understood. We show here that naive-type
mouse ESCs express high levels of a novel effector of the MAPK
and PI3K pathways. This effector is an isoform of the Gab1 (Grb2-
associated binder protein 1) adaptor protein that lacks the N-terminal
pleckstrin homology (PH) membrane-binding domain. Although
not essential for rapid unrestricted growth of ESCs under optimal
conditions, the novel Gab1 variant (Gab1β) is required for
LIF-mediated cell survival under conditions of limited nutrient
availability. This enhanced survival is absolutely dependent upon
a latent palmitoylation site that targets Gab1β directly to ESC
membranes. These results show that constitutive association of
Gab1 with membranes through a novel mechanism promotes
LIF-dependent survival of murine ESCs in nutrient-poor conditions.
KEY WORDS: Leukaemia inhibitory factor, Gab1, Embryonic stem
cells, Palmitoylation, Stem cell survival
INTRODUCTION
Embryonic stem cell (ESCs) are pluripotent cell lines derived
from the inner cell mass of the blastocyst. They are immortal,
differentiate into all foetal cell types in vitro, and most remarkably,
when reintroduced into an appropriately staged embryo, reinitiate
normal development to form all foetal tissues, including the germ line
(Martello and Smith, 2014). These characteristics make ESCs a
powerful experimental system and underpin their potential as a
biomedical resource that can provide unlimited, scalable sources of
normal cell types for regenerative therapy and drug screening.
The biological capacity and value of ESCs relies upon the fidelity
with which their developmental potential can be maintained in
culture and as a consequence, considerable efforts have been made
to understand the role of self-renewal signals and the transcriptional
factors that maintain ESC pluripotency (Ying and Smith, 2017). The
cytokine leukaemia inhibitory factor (LIF) has a crucial role in
promoting self-renewal of mouse ESCs, and the signals it elicits
have also been shown to have an important physiological role in
supporting preimplantation mouse development (Nichols et al.,
2001). Although the requirement for this cytokine in ESCs of other
species is unclear, LIF is included as a supplement in culture media
that support human stem cell lines thought to be equivalent to mouse
ESCs, and non-rodent pluripotent stem cells can respond to LIF,
suggesting that this cytokine signalling pathway may have a general
role in supporting pluripotent stem cells of mammals (Guo et al.,
2016; Takashima et al., 2014; Theunissen et al., 2014; Thomson
et al., 2012).
LIF-dependent signalling is initiated by heterodimerisation of
LIF receptor (LIFR) with gp130 (also known as IL6ST), leading to
cross-phosphorylation of receptor associated JAK tyrosine kinases.
The activated kinases then phosphorylate specific receptor tyrosines
that in turn serve as docking sites for the recruitment and activation
of downstream effectors. The key effectors include the transcription
factor Stat3, which activates expression of target genes directly, and
the tyrosine protein phosphatase SHP2 (also known as PTPN11),
which triggers the Erk/MAPK cascade and phosphoinositide
3-kinase (PI3K) signalling. Although studies have shown that
Stat3 activation of the target genes Tfcp2L1, KLF4 and Gbx2 are
critical for effective ESC self-renewal (Ying and Smith, 2017),
the contribution of LIF activation of Erk/MAPK and PI3K pathways
in ESCs is less clear (Niwa et al., 2009). Initial studies showed that
SHP2 activation is not essential for self-renewal and that general
suppression of Erk/MAPK signalling restricts mESC differentiation
(Burdon et al., 1999). Indeed, suppression of Erk (ERK1/2, also
known as MAPK3 and MAPK2, respectively) signalling
when combined with activation of Wnt/β-catenin signalling very
effectively promotes self-renewal of undifferentiated ESCs (Buehr
et al., 2008; Li et al., 2008; Wray et al., 2011; Ying et al., 2008).
This two-inhibitior (2i) culture system is enhanced further by the
addition of LIF, suggesting that Stat3 or other LIF-induced signals
are required to support efficient and robust propagation of ESCs
(Dunn et al., 2014; Li et al., 2008; Ying et al., 2008).
A candidate mediator of LIFR signalling is Gab1 (Grb2-associated
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Sevenless (DOS) family adaptor protein (Holgado-Madruga et al.,
1996; Weidner et al., 1996). In common with other IRS/DOS
proteins, Gab1 has no intrinsic enzymatic activity but functions as a
molecular scaffold to recruit and assemble signalling complexes.
Gab1 is an important mediator of Erk, PI3K and PLC signalling
induced by many growth factors, including LIF- and IL-6-related
cytokines (Nishida and Hirano, 2003; Takahashi-Tezuka et al.,
1998). The key functional elements of Gab1 include a membrane-
binding activity encoded by the N-terminal pleckstrin homology
(PH) domain, and an extended unstructured C-terminal region
that mediates protein-protein interactions with other signalling
molecules. The 110 amino acid PH domain contains seven β-sheets
capped off with a short amphipathic α-helix, forming a classic
PH-fold that contains a binding site for the phospholipid product of
PI3K, phosphatidylinositol (3,4,5)-trisphosphate (PIP3) (Maroun
et al., 1999a). Although initial recruitment of Gab1 to activated
receptors is mediated through protein-protein interactions, tyrosine
phosphorylation of Gab1 by receptor-activated kinases generates
docking sites for PI3K, which, in turn, produces the PIP3
phospholipid ligand for the Gab1 PH domain. This PI3K domain-
and PH domain-dependent positive feedback loop stabilises the
interaction between Gab1 and activated receptors and amplifies
downstream signals such as Erk via recruitment of SHP2 (Rodrigues
et al., 2000). Previously, we have shown that Gab1 is phosphorylated
by activation of the gp130 receptor in mouse ESCs (Burdon et al.,
1999). Here, we report that the predominant form of Gab1 in mESCs
is an unusual variant that lacks most of the conserved PH domain,
including the PIP3 phospholipid binding site. Nevertheless, we
unexpectedly find that this novel form of Gab1 is constitutively
associated with ESC membranes and specifically promotes LIF-
mediated ESC survival under conditions where nutrient availability
is limited.
RESULTS
A novel short form of the Gab1 adaptor protein is highly
expressed in ESCs
Stimulation of mouse ESCs via the gp130 cytokine receptor induces
phosphorylation of the Gab1 adaptor protein (Burdon et al., 1999).
However, the apparent molecular weight of Gab1 protein in mESCs,
based on electrophoretic mobility, was significantly less than the
110-115 kDa reported for the Gab1 protein of differentiated somatic
cells (Burdon et al., 1999; Holgado-Madruga et al., 1996; Weidner
et al., 1996). To understand the basis of this difference, we
compared Gab1 expression in mESCs with that in other embryonic
cell types by western blotting and found that the predominant form
of Gab1 protein in ESCs and embryonal carcinoma cells was
∼95 kDa, whereas embryonic fibroblasts and pooled tissues of a
mid-gestation embryo possessed the typical 110-115 kDa form
(Fig. 1A). Coordinated downregulation of a 4.5 kb Gab1 RNA and
the 95 kDa Gab1 protein during embryoid body differentiation
implied that the short-form Gab1 was encoded by this ESC-specific
mRNA (Fig. S1A,B). We therefore sequenced Gab1 cDNAs
obtained from an ESC cDNA library and found that all clones
possessed a novel ∼50 nucleotide non-coding 5′ exon not present in
the previously reported Gab1 cDNA, which is located ∼20 kb
downstream from the first exon containing the established Gab1
translation start codon (Fig. 1B, Fig. S1C). Apart from the novel 5′
non-coding exon, the predicted protein coding sequences of the
ESC Gab1 cDNAs was identical to that previously reported for
mouse Gab1, suggesting that translation of the ESC Gab1 protein
initiates at a methionine codon downstream of the normal Gab1
start codon. To identify this novel start codon, we transiently
transfected COS7 cells with a series of Gab1 cDNAs where
translation was initiated at each of the first four in-frame ATG
codons. Initiation at the most 5′ methionine, M104, produced a
Gab1 protein of similar mobility to that present in ESC protein
lysates. (Fig. S1D). Methionine 104 is situated at the C-terminal
boundary of the Gab1 PH domain (aa 10-117), and translation
initiation from M104 eliminates most of this critical regulatory
domain (Fig. 1C). The N-terminal PIP3 binding site that mediates
membrane localisation, and a less well-characterised putative
nuclear localisation sequence are also eliminated (Maroun et al.,
1999b; Osawa et al., 2004). Nonetheless, the 95 kDa protein should
retain all of the recognised direct protein-protein binding sites for
partners such as Grb2, the MET receptor, PI3K and SHP2 and for
our purposes will be referred to as Gab1β, to distinguish it from the
previously characterised longer form, Gab1α.
To investigate how closely Gab1β expression was associated with
the ESC state, we examined expression of the adaptor protein during
induced pluripotent stem cell (iPSC) reprogramming of embryonic
fibroblasts, and during exit from naive pluripotency to the ‘primed’
pluripotent state representative of post-implantation epiblast stem
cells (EpiSCs). Western blot analysis showed that Gab1β was not
expressed in partially reprogrammed pre-iPSCs (Fig. 1D), but was
readily detected when cells transitioned to fully reprogrammed
iPSCs derived either using standard serum/LIF, or the more
stringent 2i condition that promotes the ‘naive’ ESC ground state
(Boroviak et al., 2014, 2015; Nichols and Smith, 2009). In contrast,
Gab1β expression was absent from EpiSCs derived from post
implantation embryos (Fig. 1D). The association of Gab1β with the
naive ESC state was confirmed by monitoring the levels of Gab1
Fig. 1. Expression profile of a novel Gab1 variant protein. (A) Gab1
western blot analysis of whole cell lysates from ESCs (ES), embryonal
carcinoma (EC), 10T1/2 embryonic fibroblasts (fb) and pooled E12.5 embryo
tissues (em). The positions of the 110 and 95 kDaGab1 proteins are indicated.
(B) Schematic of the Gab1 gene locus, showing the location of the
transcription start sites for Gab1α and Gab1β, and the exons. (C) Schematic
showing the structure of Gab1α and Gab1β proteins. Dark grey and light
grey areas are proline rich-regions and the Met binding domain (MBD),
respectively. (D) Gab1 and Oct4 western blots of whole cell lysates of ESCs
(ES), primary embryonic fibroblasts (fb), pre-iPS cells (pr), iPSCs
reprogrammed in 2i medium (2i) or serum/LIF medium (sr) and an epiblast
stem cell line (Epi). (E) Quantitative RT-PCR analysis of Gab1β and Gab1α
expression in ESCs (ES) transitioned into epiblasts stem cells (Epi) and
embryoid bodies (EB). Results represent means±s.d. from one experiment.
Expression is normalised relative to the level in ESCs.
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transcripts during the transition of an ESC line through a stable
EpiSC state and into differentiated embryoid bodies (Fig. 1E).
Whereas expression of Gab1α increased as the ESCs transitioned to
the primed state and then differentiated, Gab1β transcripts were
sharply downregulated upon exit from the naive ESC state, in line
with the loss of Gab1β protein expression from the post-
implantation epiblast-derived cells (Fig. 1D). Interestingly, these
switches in Gab1 transcription are also reflected in changes in
epigenetic status of putative Gab1 promoters (Fig. S1E). In naive
ESCs, H3K4me3 histone methylation associated with active
promoters is enriched at the region immediately upstream of the
Gab1β first exon, whilst the Gab1α promoter region, by contrast, is
enriched for the repressive H3K27me3 mark commonly associated
with gene silencing.
To determine whether Gab1β was expressed during
preimplantation development in vivo, we performed RT-PCR
amplification on mouse embryos and detected transcription of the
novel 5′ exon of Gab1β in both fertilised oocytes and blastocysts
(Fig. S2A). Gab1β transcription was also detected in primordial
germ cells and western blot analysis indicated a low level expression
of the 95 kDa protein in the adult testis (Fig. S2A,B). By contrast,
Gab1β protein was not readily detected in most other adult mouse
tissues, suggesting that high level expression was primarily
restricted to ESCs and germ cells (Fig. S2B).
Gab1 transcripts containing alternative 5′ exons have also been
found in EST cDNA libraries in animals ranging from frogs to
humans (Fig. S1C). The corresponding Gab1β exon in mouse was
identified by cap-analysis of gene expression (CAGE), a technique
that maps 5′ transcription initiation sites, providing evidence that a
promoter within intron 1 drives expression of Gab1β (Fig. S2C).
Transcription initiation at this site was also detected in trophoblast
stem cell lines, suggesting that although this variant form of Gab1
protein is enriched in ESCs, expression may not be exclusive to
pluripotent cells of the early mouse embryo.
Gab1β promotes LIF-dependent signalling in ESCs
To evaluate the contribution of Gab1β to signalling in ESCs, we first
examined tyrosine phosphorylation of Gab1β in response to the
growth factor supplements LIF and foetal calf serum used in
routine ESC cultures (Fig. 2A,B). Western blot analysis of Gab1
immunoprecipitates showed that the overall level of Gab1β tyrosine
phosphorylation increased only slightly in response to LIF or serum.
In contrast, however, tyrosine phosphorylation at specific SHP2
(Y627) and PLCγ (Y307) binding sites increased markedly in
response to LIF, demonstrating that Gab1β is phosphorylated at
recognised docking sites following stimulation of LIFR. Consistent
with this phosphorylation pattern, SHP2 immunoprecipitates from
LIF-induced ESCs contained Gab1β (Fig. 2B). Gab1β was also
constitutively associated with the adaptor proteins p85 (the non-
catalytic subunit of PI3K), Grb2 and ShcA in ESCs (Fig. S3A,B).
Without the PH domain to stabilise its association with the
plasmamembrane, Gab1βmight not be able to effectively propagate
downstream signals since, theoretically, the adaptor protein should
be unable to participate in the PH-domain/PI3K/PIP3-dependent
amplification mechanism (Rodrigues et al., 2000). Gab1β might
even operate as a molecular sponge or decoy to dampen downstream
effector functions. To determine howGab1β influences downstream
signalling we generated ESC lines that specifically lack Gab1β, but
retain Gab1α expression. This was achieved by two consecutive
rounds of homologous recombination with targeting vectors in
which hygromycin- and blasticidin-resistance genes were inserted
into the unique Gab1β 5′ exon (Fig. S3C,D,E).
To assess the role of Gab1β in LIF signalling, we examined
phosphorylation of Akt, Erk and Stat3 in wild-type ESCs, in Gab1β
KO ESCs, and in KO clones where we either restored Gab1β
expression, or overexpressed Gab1α using stably integrated cDNA
expression vectors (Fig. 2C). Whilst LIF-stimulated Stat3
phosphorylation was similar in all cell lines, the induction of Akt
and Erk phosphorylation by LIF was noticeably reduced in Gab1β
KO ESCs compared with levels in Gab1β wild-type ESCs.
However, reconstitution of Gab1β or overexpression of Gab1α in
Gab1β KO cells increased both Akt and Erk phosphorylation
compared with levels in Gab1β KO cells. In contrast, Gab1β
expression did not appear to play a significant role in serum-induced
phosphorylation of Erk (Fig. S3F,G). These results demonstrated
that despite not having a PH domain, Gab1β contributes to
signalling downstream of LIFR in ESCs.
Gab1β expression provides a growth advantage in
high-density ESC cultures
To assess the biological function of Gab1β in ESCs, we first
examined stem cell self-renewal, making use of the ESC-specific
Pou5f1-βgeo knock-in allele in the IOUD2 parental ESC line,
which allows the growth of undifferentiated stem cells to be
monitored by measuring Pou5f1-lacZ-derived β-galactosidase
activity (Mountford et al., 1994). We compared β-galactosidase
activity in wild-type and Gab1β KO IOUD2 cells in self-renewal
assays and found that the cell lines exhibited similar levels of self-
renewal in response to different concentrations of LIF (Fig. S4A),
indicating that Gab1β expression did not affect ESC self-renewal at
the low cell densities used in these self-renewal assays.
Fig. 2. Gab1β as an ESC signal transducer. (A) Western blot of Gab1
immunoprecipitates from unstimulated ESCs (−), and ESCs stimulated with
serum (sr) or LIF (lf ) for 10 min, probed with Gab1pY627, Gab1pY307,
phosphotyrosine and Gab1 specific antibodies. The dashes indicate position of
100 kDa MWmarker. (B) Western blot of SHP2 immunoprecipitates from cells
treated as in A probed with antibodies to Gab1 and SHP2. (C) Western blot of
cell lysates fromwild-typeESCs,andGab1βknockoutESC linestably transfected
with empty vector (−/−), Gab1β, and Gab1α expression vectors, unstimulated
or following stimulation with LIF for 15 min. The blot was incubated with
antibodies to phospho-Akt, Akt, phospho-Erk, Erk1/2, phospho-Stat3 andGab1.
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To investigate whether Gab1β expression affects ESC growth at
higher cell densities, we examined the behaviour of Gab1β-deficient
ESCs in near confluent cultures. We used Gab1β mutant cell lines
generated from the standard wild-type E14Tg2a parental cells
(Fig. S4B,C), to exclude concerns that genetic modification of the
Pou5f1 gene might affect the response of cells in high-density
assays (Karwacki-Neisius et al., 2013). Consistent with the previous
IOUD2 experiments, self-renewal assays in the E14Tg2a Gab1β-
expressing and KO lines did not reveal any consistent differences
(Fig. S4D). When we plated two independent Gab1β heterozygous
and two Gab1β KO E14Tg2a clones at densities typical of those
routinely used for propagating ESC lines (∼105 cells/cm2), the
initial growth of the cell lines was indistinguishable in the first
2-3 days. However, once the lines approached confluence it
appeared that the survival of Gab1β-expressing heterozygous cells
was noticeably greater than that of the Gab1β KO cells (Fig. 3A).
Monitoring ESC growth by measuring live cell DNA-dependent
fluorescence daily throughout a 6-day culture period confirmed that
the growth of all four clones was very similar for the first 2 days.
However, between the 3rd and 4th days, when cell growth slowed,
the Gab1β-expressing heterozygous cells attained higher cell
numbers and maintained higher levels for an extended period
(Fig. 3B). Statistical analysis showed that from day 3 onwards, the
mean live cell DNA fluorescence differed significantly between the
Gab1β heterozygous and KO cells. To confirm that this effect was
due to Gab1β expression, we repeated the growth experiments using
pools of Gab1β KO cells stably transfected with either a Gab1β
expression vector or an EGFP control, and compared them with a
pool of Gab1β heterozygous clones transfected with a mCherry
expression control vector (Fig. 3C). As with previous experiments,
the cell lines showed similar rates of growth during the first two
days, but between day 3 and day 4, the Gab1β-restored and
heterozygous cells exhibited a growth or survival advantage over
the KO cells lacking Gab1β. There was a statistically significant
difference between the live cell DNA fluorescence in EGFP control
and Gab1β-expressing cells on days 4-6, but not between the Gab1β
heterozygous mCherry-transfected cells and Gab1β-expressing
cells (Fig. 3C). Collectively, these results establish that Gab1β
expression provides a growth or survival advantage in high cell
density culture conditions.
Gab1β promotes ESC survival in nutrient-depleted
conditions
To determine the cause of the growth advantage associated with
Gab1β expression, we examined cell proliferation and apoptosis in
near-confluent ESC cultures. The cell cycle profiles of Gab1β-
expressing and non-expressing cells were determined by measuring
DNA content by flow cytometry. The overall profiles were
indistinguishable during either the rapid or plateau growth phases,
although as expected, there was a noticeable reduction in the S-phase
contribution in both cell types during the plateau phase (Fig. 4A).
However, it was evident that Gab1β KO cells accumulated a greater
amount of sub-diploid/fragmented cells at day 3 during the plateau
growth phase, pointing to increased levels of cell death in these
cultures (Fig. 4A,B). We therefore used flow cytometry to assess the
level of apoptosis by measuring the percentage of live cells that were
positive for the apoptotic maker Annexin V. While equivalent levels
of early apoptosis were observed at day 1 in both ESC cultures, at day
2 therewas amarked increase in Annexin V staining in the Gab1βKO
cells (Fig. 4C). Caspase 3/7 activation and cytotoxicity, reflecting
general cell death, were both noticeably higher in the day 2/3 Gab1β
KO cultures, further supporting the notion that absence of Gab1β
was associated with increased levels of apoptosis (Fig. 4D).
Taken together, these results suggest that expression of the Gab1β
protein in ESCs promotes cell survival when culture conditions
become restrictive.
In high-density cultures a number of factors including
environmental, physical or metabolic might limit ESC growth.
Fig. 3. Function of Gab1β in ESCs.
(A) Undifferentiated ESCs identified by alkaline
phosphatase activity (pink stain) in two Gab1β
heterozygous (HET) and two Gab1β knockout
(KO) E14Tg2a cell lines 5 days after plating. Scale
bars: 200 µm. (B) Growth curves of Gab1β
heterozygous (HET) and Gab1β knockout (KO)
E14Tg2a cell lines measured by DNA-dependent
fluorescence in live cells. Cells were plated at a
density close to that for routine passaging of ESCs
(6×104 cells/cm2) and DNA fluorescence was
measured daily for 6 days. The data represent the
mean±s.e.m. of three independent experiments.
Statistical analysis using Student’s t-test showed
significant differences between the means for the
HET and KO lines from day 3 to day 6 (P≤0.005).
(C) Growth curves performed as described in
B with pooled transfected ESCs: Gab1β
heterozygous (HET-mCherry), Gab1β knockout
(KO-EGFP) and Gab1β knockout stably expressing
Gab1β from a cDNA expression vector (KO-Gab1β).
Student’s t-test analysis showed significant
differences between the KO-EGFP and KO-Gab1β
lines from day 4 to day 6 (P<0.0001), but not
between HET-mCherry and KO-Gab1β cells.
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To distinguish between these alternatives, we modified the culture
environment and monitored the effects on ESC growth. To
investigate what factors affect the growth profile, we treated ESCs
with an inhibitor of the enzyme mTOR (mammalian/mechanistic
target of rapamycin), a key enzyme that senses and controls nutrient
availability in cells, and is a regulator of anabolic process such as
protein, lipid and nucleotide synthesis (reviewed in Saxton and
Sabatini, 2017). Addition of 25 nM mTOR inhibitor (INK128)
restricted the initial growth rate of Gab1β-expressing and non-
expressing cells equally and reduced the maximum cell numbers
achieved in both cases (Fig. 5A). Under these restrictive conditions
the growth or survival advantage of the Gab1β-expressing cells was
still apparent, even though it occurred at lower cell numbers,
implying that it was unlikely that cell density was responsible for
limiting the later phase of ESC growth.
To determine whether nutrients might be limiting the growth of
Gab1β-deficient ESCs, we tested how supplementation with
medium components affected ESC culture growth and survival at
the plateau phase (Fig. 5B,C). Addition of either standard DMEM,
or DMEM lacking glucose, sodium pyruvate and glutamate at day 2
of culture improved the survival of Gab1β KO ESCs, suggesting
that depletion of amino acids or vitamin supplements common to
both growth media become limiting for ESC growth during the
plateau phase, and excluded the depletion of energy sources such as
glucose as being directly responsible for slowing ESC growth.
Direct supplementation of plateau phase cultures with glutamine or
sodium pyruvate also did not appreciably improve ESC survival or
growth (Fig. S5).
Gab1β-mediated ESC survival is LIF dependent
We have shown that Gab1β is phosphorylated after stimulation
of the LIFR, and activates downstream signalling (Fig. 2). To
determine whether LIF signalling was also required for Gab1β-
mediated ESC survival in nutrient-depleted cultures, we compared
the growth of Gab1β-expressing and non-expressing cells with or
without LIF over 6 days. Whereas cells in all conditions grew
rapidly for the first 2 days, in both Gab1-expressing and KO cultures
deprived of LIF, cell numbers declined rapidly after this point in a
manner similar to that displayed by Gab1β KO cells cultured in the
presence of LIF (Fig. 6A). This demonstrated that ESC survival in
post-confluent cultures relies on LIF signalling and also depends on
Gab1β expression. Although unlikely, it is possible that the loss of
cell viability seen here is a result of ESC differentiation initiated by
LIF withdrawal. To address this possibility, we restricted ESC
differentiation by including the Mek (MEK1/2; also known as
MAP2K1 and MAP2K2) inhibitor PD0325901 in the LIF-deficient
Fig. 4. Gab1β regulation of ESC cell cycle
and apoptosis. (A) Flow cytometry cell cycle
analysis of Gab1β-expressing or non-
expressing ESCs. Triplicate ESC samples were
collected on day 2 and 3 of culture, fixed and
stained using propidium iodide, and analysed
by flow cytometry. Representative scans are
shown and sub-diploid cell material is indicated
with an asterisk. (B) Quantification of cell cycle
distribution. Mean±s.d. values of cell cycle
phases generated from three independent
cultures (Student’s t-test, *P<0.005). (C) Flow
cytometry of Annexin V staining in day 1 and day
2 ESC cultures. Grey and black bars are values
from Gab1β KO and Gab1β-expressing (Gab1β
KO+Gab1β cDNA vector) ESCs, respectively
(Student’s t-test, *P<0.005). (D) Apoptosis,
cytotoxicity and viability assays of day 2 cultures
of Gab1β KO and Gab1β-expressing ESCs.
Values are means±s.d. of four biological
replicates (apoptosis and cytotoxicity t-tests,
P<0.0001; viability t-test, P<0.005).
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high-density cultures. However, this did not improve ESC survival
(Fig. 6A), and may even have compounded the effects of LIF
withdrawal. To explore the relationship between Gab1β and
LIFR-mediated cell survival, we examined the LIF dose response
of ESC cultures (Fig. S6A,B). Whereas the survival of the Gab1β-
expressing cells at the plateau phase was dependent on the dose of
LIF, the acute collapse in viability of the majority of the Gab1β KO
cells was largely independent of the dose.
Survival of Gab1βKOESCs is rescued by inhibition of FGFRor
Mek activity
The studies above were performed under standard serum+LIF
culture conditions, but we were interested in determining how
Gab1β expression might affect ESC growth and survival under
culture conditions, such as 2i+LIF, that selectively promote the
naive ESC state. We found that while cell proliferation in the
initial growth phase was similar to that in serum-containing
medium (Fig. 6B), in the post-plateau phase, Gab1β KO cell
survival in 2i+LIF medium was markedly better than in
serum+LIF medium, and comparable to cells expressing Gab1β.
There were differences in growth characteristics of ESCs in
2i+LIF serum-free and serum+LIF medium, with 2i+LIF cells
forming more compact and tighter colonies. Nonetheless, these
results indicate that conditions induced by 2i+LIF compensate for
the absence of Gab1β in the Gab1β KO cells. To determine how
2i+LIF contributes to this ‘rescue’ effect, we inhibited either Mek
or its upstream activator FGFR (fibroblast growth factor receptor)
in the standard serum+LIF conditions. Treatment of cells with
Mek inhibitor or the FGFR inhibitor PD173074 had little effect
on the initial rate of expansion of ESCs but in both cases improved
the survival of the Gab1β KO cells (Fig. 6C,D). Taken together,
these results indicate that the survival function of Gab1β and
inhibition of FGFR- and Mek-dependent activities converge to
promote ESC survival.
Gab1β is located at ESC membranes
Localisation of Gab1 at the cell membrane is thought to be critical
for its functional activity and yet, despite lacking an intact PH
domain, Gab1β contributes to ESC signalling and promotes ESC
survival. To understand how Gab1β could influence ESC survival
without the PH domain, we examined the cellular location of Gab1β
in ESCs. Based on previous reports, a Gab1 protein lacking the
phospholipid binding site contained within the PH domain should
be located in the cytoplasm (Maroun et al., 1999b; Rodrigues et al.,
2000). However, when we compared the location of Gab1 protein in
wild-type and Gab1β KO ESCs using immunocytochemistry (with
the antibody that recognises both Gab1α and -β forms), it was clear
that a significant proportion of Gab1 protein localised to the cell
membrane in wild-type cells (Fig. 7A). By contrast, in Gab1β KO
cells there was very little membrane-associated Gab1 protein
(Fig. 7B). Crucially, stable expression of a Gab1β cDNA in the KO
cells restored the wild-type distribution of Gab1, demonstrating that
Gab1β in ESCs is normally located at the cell membrane (Fig. 7C).
To determine how Gab1β is directed to the membrane, we
examined the cellular localisation of Gab1-EGFP fusion proteins
stably expressed in the Gab1β KO cells. Whereas the Gab1β-EGFP
fusion protein carrying EGFP at the C-terminus of Gab1β was
located predominantly at the ESC membrane (Fig. 7D), the
corresponding Gab1α-EGFP protein was largely cytoplasmic,
with only a minority of ESCs displaying membrane-associated
Gab1α-EGFP (Fig. 7E). Significantly, a fusion protein in which
EGFP was attached to the N-terminus of Gab1β was entirely
cytoplasmic (Fig. 7F). This result suggested that the membrane-
targeting signal of Gab1β can be blocked by attachment of EGFP, or
the PH domain, and is therefore likely to be located close to the
N-terminus of the protein.
Gab1 proteins that lack the entire PH domain (amino acids
10-117) have been shown to be located in the cytoplasm (Maroun
et al., 1999b; Rodrigues et al., 2000). However, these artificial
mutants are not directly comparable to Gab1β-expressing cells as we
noted that the N-terminus of Gab1β retains an additional 15 amino
acids (15 aa) from the end of the PH domain. This 15 aa polypeptide
forms a structurally conserved amphipathic helix that typically caps
off PH domains (Lemmon and Ferguson, 2000). To examine the
contribution of this 15 aa polypeptide, we deleted this element from
the Gab1β-EGFP fusion protein and found in agreement with
previous reports (Maroun et al., 1999b; Rodrigues et al., 2000) that
the Gab1β-Δ15aa-EGFP protein was located in the cytoplasm
(Fig. 7G). To examine directly how the N-terminal region of Gab1β
contributes to membrane targeting, we examined the localisation of
EGFP fusion proteins carrying the N-terminal 47 amino acids
(aa 104-150) or just the 15 amino acid peptide (aa 104-118) of
Gab1β (Fig. 7H,I). The 47aa-EGFP fusion protein was very clearly
located at the membrane. In comparison, the 15aa-EGFP fusion
protein exhibited a weaker signal at the membrane and evidence of
an irregular distribution throughout the cytoplasm. Taken together,
Fig. 5. Gab1β and ESC response to
nutrient availability. (A) Growth profiles of
Gab1β KO and Gab1β-expressing ESCs
treated with 25 nM mTOR inhibitor INK128
(mTORi). Values aremeans±s.e.m. of three
independent experiments. (B,C) Growth of
Gab1β KO and Gab1β-expressing ESC
cultures supplemented on day 2 with 10 µl
PBS, regular DMEM (+) or DMEM (−)
lacking glucose, glutamine and sodium
pyruvate. Values are means±s.d. of three
biological replicates.
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these experiments suggest that the N-terminal region of Gab1β,
containing the residual 15 aa α-helical region derived from the PH
domain, is sufficient to target Gab1β to the ESC membrane. Gab1β
protein also accumulated at an intracellular site in most ESCs
(Fig. 7A,C), as did the Gab1β-EGFP and 47aa-EGFP fusion
proteins (Fig. 7D,H), indicating that Gab1β may also associate with
the membranes of intracellular vesicles.
Palmitoylation of Gab1β drives its membrane localisation
and function
Our localisation experiments demonstrate that the 15 aa N-terminus
of Gab1β contains a signal that targets it to ESC membranes.
Examination of this region identified three cysteines that were
potential sites for palmityolyation: a lipid modification that could
account for the stable association of Gab1β with the cell membrane
(Fig. 8A). The three cysteines are conserved to different extents
amongst Gab family members, including the Gab1 homologues DOS
inDrosophila and SOC-1 inCaenorhabditis. To test directly whether
Gab1β is palmitoylated in ESCs, we cultured ESCs expressing Gab1-
EGFP fusion proteins in the presence of [3H]palmitate and examined
3H-labelling of EGFP immunoprecipitates after electrophoresis
and transfer to an immobilising filter. Autoradiography revealed
that Gab1β and the 47 aa fusion constructs were labelled efficiently
with [3H]palmitate (Fig. 8B). By contrast, deletion of the 15aa
region from Gab1β, or alanine substitution of the three cysteines in
the 47 aa fusion protein (47aa-CA3m-EGFP), prevented labelling.
Interestingly, 3H-labelling of Gab1α or Gab1 PH-domain–EGFP
fusion proteins could not be detected, demonstrating that in the
presence of the intact PH domain Gab1 palmitoylation is suppressed
or at least was inefficient under these experimental conditions. To
determine how palmitoylation of Gab1 affects membrane targeting,
we examined the localisation of the 47aa-CA3m-EGFP in ESCs and
found that alanine substitution of the three cysteines in this mutant
abolished membrane targeting of the fusion protein (Fig. 8C).
Significantly, the identical alanine substitutions within the context of
the PH-domain–EGFP fusion protein did not prevent localisation at
the membrane (Fig. 8C).
These results strongly suggest that palmitoylation of the
N-terminal domain drives membrane localisation of Gab1β in ESCs.
We therefore determined whether palmitoylation of Gab1β was
also associated with supporting ESC survival. We compared the
growth of Gab1β KO ESCs with cells stably expressing cDNAs
encoding either Gab1β or a Gab1β-CA3 mutant. In contrast to cells
expressing wild-type Gab1β, ESCs expressing the Gab1β-CA3
Fig. 6. Gab1β-mediated ESC survival
depends on LIF, and is rescued by Mek
inhibition.Growth profiles of Gab1βKO and
Gab1β-expressing ESCs cultured in the
presence or absence of: (A) LIF (±1 µM
PD0325901 Mek inhibitor); (B) 2i (1 µM
PD0325901Mek inhibitor, 3 µMCHIR99021
GSK3 inhibitor) +LIF serum free medium;
(C) FGFR inhibitor PD173074 (one
experiment with quadruplicate biological
samples; and (D) 1 µM PD0325901 Mek
inhibitor. Data points in A,B and D represent
the means±s.e.m. of three independent
experiments Data points in graph C
represent the means from four biological
replicates in one experiment. For all graphs,
Student’s t-tests showed statistically
significant differences between serum+LIF-
treated KO and Gab1β-expressing control
lines at days 4-6 (P≤0.0001), and between
KO control and KO treated (KO+Meki) cells
(P≤0.0001).
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mutant protein exhibited the same growth profile as the Gab1β KO
cells, showing that the palmitoylation of Gab1β and localisation at
the ESC membrane is required for Gab1β-dependent ESC survival
in culture (Fig. 8D).
DISCUSSION
LIFR-gp130 signalling has essential roles during early embryonic
development that provide the physiological rationale for the
contribution of this signalling pathway to the growth and self-
renewal of embryonic stem cells (ESCs) in culture (Do et al., 2013;
Nichols et al., 2001). Here, we report the identification of a novel
variant form of the adaptor protein Gab1 (Gab1β) that contributes to
LIF-dependent survival of ESCs under conditions of limited
nutrient availability. In this Gab1 variant the domain that
normally regulates the access of the protein to the membrane and
to activated receptors is replaced with a lipid tag that anchors the
Gab1β adaptor protein constitutively at the cell membrane.
Although disruption of Gab1 expression does not normally
disturb pre-gastrulation embryo development, we presume that the
switch in regulatory modes may confer an additional growth or
survival advantage under exceptional circumstances (Itoh et al.,
2000; Sachs et al., 2000). Since Gab1β is expressed in cells
representative of the early preimplantation epiblast and the
trophoblast stem cell compartment, we speculate that a primary
function of Gab1β is to support preimplantation embryos exposed to
suboptimal environmental conditions in the uterus.
The abundance of Gab1β protein and its phosphorylation
following treatment with LIF suggested that the adaptor protein
has a functional role in ESCs. Under the standard clonal culture
conditions typically used to assess growth and self-renewal, ESCs
tolerated the loss of Gab1β. However, when challenged with
nutrient-limited conditions, Gab1β expression reduced cell death
and extended the viability of ESCs. When cells were treated with an
inhibitor of the key nutrient sensor and anabolic regulatory enzyme
mTOR, Gab1β expression improved ESC survival, which could
imply that availability of nutrients is a contributory limiting factor.
Indeed, rescue of starved ESC cultures by supplementation with
minimal basal medium indicated that lack of either amino acids or
vitamins was responsible for collapse of the cultures. It has been
reported that restricting ESC growth induces a state that resembles
the quiescent condition induced in embryos during delayed
implantation (also known as diapause) (Renfree and Shaw, 2000).
In vivo, preimplantation blastocysts undergo developmental arrest
and implantation is delayed in order to synchronise embryo
development with the mother’s reproductive capacity and
environmental inputs. Importantly, inhibition of mTOR is reported
to suppress ESC growth and to maintain a ‘paused’ quiescent, but
developmentally competent, state in ESCs and blastocysts for over a
week (Bulut-Karslioglu et al., 2016). This suggests that nutrient
availabilitymay determine entry into this quiescent condition and this
state can be induced experimentally in culture.
A role for Gab1β in ESC survival was evident in LIF-treated
cultures. Gab1β expression also increased LIFR-mediated Erk and
Akt phosphorylation, directly implicating the adaptor as a transducer
of LIFR signals. PI3K/Akt signalling has been shown to be involved
in Gab1-mediated cell survival, and in ESCs, activation of this
pathway has been reported to promote cell growth, survival and
self-renewal (Cherif et al., 2015; Fan et al., 2016; Fukumoto et al.,
Fig. 7. Localisation of Gab1β at the cell
membrane. Confocal images of (A) wild-type
ESCs, (B) Gab1β knockout ESCs and (C) Gab1β
knockout ESCs stably transfected with a Gab1β
cDNA expression vector, immunostained with
antibodies against Gab1 (red) and
counterstained for DNA with DAPI (blue).
(D-I) Confocal images of EGFP fluorescence in
ESC stably expressing the following Gab1-
EGFP fusion proteins: (D) Gab1β-EGFP;
(E) Gab1α-EGFP; (F) N-terminal EGFP-Gab1β;
(G) Gab1β-EGFP fusion lacking 15 N-terminal
amino acids; (H) the 47 N-terminal amino acid
peptide of Gab1β fused to EGFP; and (I) 15 N-
terminal amino-acid peptide of Gab1β fused to
EGFP. White arrows highlight consistently
observed intracellular accumulations of Gab1β
proteins. Scale bars: 10 µm.
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2009; Furuta et al., 2016; Hishida et al., 2015; Holgado-Madruga
and Wong, 2003; Holgado-Madruga et al., 1997; Jirmanova et al.,
2002; Paling et al., 2004; Sun et al., 2014; Watanabe et al., 2006).
By contrast, Erk activation is normally associated with ESC
differentiation, and inhibition of Mek-Erk signalling promotes ESC
self-renewal (Burdon et al., 1999; Ying et al., 2008). Notably,
inhibition of either FGFR or Mek activity improved the survival of
Gab1β-KO ESCs, and appeared to largely rescue the Gab1β
deficiency. Indeed, it has been reported that Mek inhibition reduces
the requirement for PI3K signalling in ESCs, thus potentially
uncoupling cells from the requirement for PI3K-dependent survival
signals provided by Gab1β (Hishida et al., 2015). A possible
alternative explanation is that Gab1β might be a physiological
disruptor of Mek signalling by altering the activation kinetics of the
pathway, or by binding Erk and regulating access of this kinase to its
target proteins (Osawa et al., 2004; Wolf et al., 2015).
Membrane localisation of Gab1β is essential for its survival
function and is dependent on palmitoylation of this ESC adaptor
protein. The lipid modification targets Gab1β to ESC membranes,
liberating Gab1β from dependence on PI3K activity and availability
of the phospholipid PIP3, and locates the adaptor in close proximity
to upstream effectors such as receptors and associated kinases.
Removal of the PH domain also eliminates an auto-inhibitory
interaction between the PH domain and C-terminal region of Gab1
(Eulenfeld and Schaper, 2009; Wolf et al., 2015). This blocks PIP3
binding by the PH domain, but can be relieved by Erk-mediated
phosphorylation of the C-terminal domain. Freed from this
regulatory constraint, Gab1β should be constitutively available to
associate with receptors and maintain the basal level of Gab1β
phosphorylation observed in ESCs. Nonetheless, Gab1β cannot
participate in the PH-domain/PI3K/PIP3 positive feedback loop and
therefore will be limited in its capacity to amplify downstream
signalling. Understanding why Gab1β expression is preferred in
ESCs rather than upregulation of Gab1α expression should provide
insights into how quantitative and qualitative aspects of signalling
affect cell behaviour in the early embryo. Perhaps direct association
of Gab1β with the cell membrane increases sensitivity to
LIFR-gp130-mediated activation, but limits the intensity and
duration of signalling to curb differentiation or proliferation – thus
supporting stem cell survival under growth-restrictive conditions.
Gab variants with alternative N-terminal sequences have been
described previously. A hamster Gab1 protein (Gab1Δ1-103)
analogous to Gab1β, enhances anchorage-independent growth
of preneoplastic fibroblasts (Kameda et al., 2001), and PH-
domain-deficient isoforms have also been reported for the closely
related Gab-family member Gab2 (Adams et al., 2012; Gu et al.,
Fig. 8. The N-terminus of Gab1β directs
palmitoylation and is required for
membrane localisation and function.
(A) Schematic outlining the structure of the
Gab1 PH domain and comparison of the
N-terminus of Gab1β with corresponding
regions of other Gab-related proteins. The
arrangement of the seven β-sheets and
the α-helix, and relative positions of a
putative nuclear localisation sequence
(NLS) and PIP3 binding residues are
shown. Cysteines within the α-helix are
highlighted in bold. (B) EGFP
immunoprecipitates from ESCs stably
transfected with EGFP or Gab1-EGFP
fusion proteins cultured overnight with
[3H]palmitate, were fractionated on an
SDS protein gel, transferred to a filter and
autoradiographed (top) and probed for
EGFP protein (bottom). CA3 designates
variants in which the three N-terminal
cysteines of Gab1β are substituted with
alanine. (C) Confocal images of EGFP
fluorescence in ESCs transfected with the
47-EGFP, 47CA3-EGFP, PH-domain
EGPF and PH-domain CA3-EGPF fusion
proteins (counterstained with DAPI). Scale
bars: 10 µm. (D) Growth curves of Gab1β
knockout (KO) ESCs andGab1βKOESCs
stably transfected with either Gab1β wild-
type or CA3 mutant cDNA expression
vectors. The graphs represent the means
±s.e.m. obtained from three independent
experiments. Student’s t-test analysis
showed significant differences between
the KO and Gab1β-expressing lines from
day 4 to day 6 (P<0.0001), but not between
KO and KO-Gab1β:CA3m cells.
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1998, 2001). Interestingly, membrane localisation of another
IRS/DOS family member, fibroblast growth factor receptor
substrate 2 (FRS2) depends upon myristoylation to target this
adaptor protein to the cell membrane and enable its participation in
downstream signalling (Kouhara et al., 1997). Gab protein variants
may therefore exemplify a more general mechanism for diversifying
the intracellular locations of this class of adaptor proteins and their
contribution to signalling.
Gab1β is highly expressed in ‘ground state’ naive ESCs that
are thought to closely represent the epiblast of the preimplantation
embryo (E3.75-E4.5) (Boroviak et al., 2014). Interestingly, although
Gab1β expression is down-regulated during the transition to form
EpiSCs, a cell type representing the post-implantation epiblast
(Brons et al., 2007; Tesar et al., 2007), high levels of Gab1β
transcription are also detected in trophoblast stem cells. This may
indicate that Gab1β transcription is regulated by factors common
to both epiblast and trophoblast stem cells, and additionally point
to Gab1β having a broader role in regulating the viability of cells
within the whole preimplantation embryo.
In conclusion, Gab1β is highly expressed in rodent ESCs and
supports LIF-dependent survival when nutrient availability becomes
limiting. How Gab1β and its downstream effectors interact with the
regulatory machinery of cells in the preimplantation embryo, and
their relevance to conditions prevalent in vivo deserves further
consideration and could provide new insights into the control of
embryo survival.
MATERIALS AND METHODS
Cell culture and transfections
ESCs were cultured without feeder cells in Glasgow modification of
Eagle’s medium (GMEM) containing 10% foetal calf serum, 0.1 mM
2-mercaptoethanol and LIF as described previously (Chambers et al., 2003;
Hooper et al., 1987; Mountford et al., 1994; Niwa et al., 2000; Smith, 1991).
R2 pre-iPS cells were cultured on irradiated DIAM feeders (Meek et al.,
2010) in GMEM/FCS (Theunissen et al., 2011). iPS cells were cultured in
2i+LIF medium (Theunissen et al., 2011) or with GMEM/FCS/LIF as
described for ESCs above. EpiSC cells were grown on fibronectin-coated
plates in N2B27 medium containing activin (20 ng/ml) and FGF2 (12 ng/ml)
(Guo et al., 2009; Osorno et al., 2012). PSMB embryonal carcinoma, primary
mouse embryonic fibroblasts, COS7, NIH 3T3 and C3H 10T1/2 cells were
maintained in ESC culture medium without LIF. For routine ESC culture,
LIF was generated in-house. For inductions and growth experiments,
ESGRO recombinant mouse LIF protein (ESG1107) was obtained from
Merck. The small-molecule inhibitors PD0325901 (#1408) and CHIR99021
(#1386) were obtained from Axon Medchem, and PD173074 (S1264)
from Selleckchem.
COS7 were transfected using the Fugene 6 transfection reagent in
accordance with the manufacturer’s instructions (Roche Molecular
Biochemicals) at ∼50% confluence, were incubated for 72 h with 2 µg of
supercoiled plasmid DNA complexed with 5 µl Fugene and then harvested
for protein analysis. Transfected ESCs were obtained by incubating the cells
(0.5-1×106 cells per well of 6-well dish) with 5 µg of plasmid DNA using
Lipofectamine 2000 reagent (Life Technologies) for 36 h. ESC clones stably
transfected with Gab1 expression vectors were selected in ESC medium
containing puromycin (1 µg/ml) or hygromycin (100 µg/ml) (for 10 days,
then trypsinised and combined to establish pooled cultures for each construct.
For growth factor induction experiments, ESCs were cultured overnight in
GMEM base medium lacking glutamine and serum prior to stimulation
with growth factors. E14/T cells were super-transfected with supercoiled
plasmids carrying the polyoma origin of replication, as described previously.
Cloning of Gab1 cDNAs and expression constructs
The mouse Gab1α cDNA was generated by RT-PCR using a Superscript
preamplification system (Invitrogen) to reverse transcribe 1 μg of total RNA
from C3CH10T1/2 fibroblasts. 1/10th of the reaction was amplified using
Expand High fidelity polymerase (Roche) with 5′ GGGCGGCCGCCGC-
ACCATGAGCGGTGGTGAAGTG and 3′ CCCTCGAGTCACTTCA-
CATTCTTGGTGGGTG oligonucleotide primers containing NotI and
XhoI restriction sites, respectively (underlined). Thirty cycles of PCR
generated the expected 2 kb DNA fragment, which was restricted with NotI
and XhoI, subcloned and sequenced. Gab1β cDNAs were isolated from an
ESC cell cDNA library provided by Dr Hitoshi Niwa ( Institute ofMolecular
Embryology and Genetics, Kumamoto, Japan). Three independent clones
were sequenced at their 5′ and 3′ ends and one clone sequenced on both
strands of the coding region. Gab1α and Gab1β cDNAs were restricted with
NotI and XhoI and subcloned into pCAGIH a hygromycin-resistant
derivative of the pCAGIZ expression vector (Jackson et al., 2002; Niwa
et al., 1998). This plasmid contains the SV40 origin sequence, allowing
efficient transgene expression in cells harbouring the SV40 large T antigen.
A progressively truncated series of Gab1 cDNAs, M104, M151, M232 and
M240, were generated by PCR amplification. Reactions were performed
with a 5′ primer containing a NotI restriction site and Kozak consensus
immediately upstream of the ATG initiation codon plus 16-19 nucleotides of
downstream Gab1 sequence and a 3′ primer containing a XhoI restriction
site. The amplified products were subcloned into the pCAGIH expression
vector as NotI/XhoI fragments. Gab1-EGFP- or Gab1-myc-tagged fusion
proteins were generated by PCR amplification of Gab1 regions cloned in
pCAGIH (or puro version pCAGIP) modified vectors, upstream of an open
reading frame containing either a poly glycine-EGFP protein, or a triple
myc-tag, respectively. The 15 aa N-terminal region of Gab1β was cloned
upstream of EGFP as a double-stranded oligonucleotide. The sequences of
the oligonucleotide primers used to generate the Gab1 coding regions are
available on request. Gab1 expression vectors were linearised with SfiI prior
to transfection. Drug-resistant ESC colonies were picked individually or
pooled to establish stably transfected cultures.
Preparation of embryonic RNA and RT-PCR analysis
Embryos and cells were prepared from appropriately staged strain 129
female mice. After flushing from the oviduct, oocytes were treated with
hyaluronidase to remove cumulus cells. Both oocytes and blastocysts were
washed extensively to eliminate contaminating cellular debris prior to lysis.
Primordial germ cells (PGCs) were isolated from the dissected genital
ridges of day 12.5 embryos, using calcium- and magnesium-free phosphate
buffered saline (Buehr and McLaren 1993). Freshly prepared oocytes
(n=35), blastocysts (n=30) and PGCs were lysed in Solution D and RNA
was purified by acid phenol extraction (Chomczynski and Sacchi, 1987).
To aid recovery of RNA, 20 µg of carrier tRNA was added to the samples
prior to extraction. cDNA was prepared from 1/5th of the recovered RNA
using random priming and the Superscript Preamplification system. 1/10th
of the reverse transcription reaction was then amplified using AmpliTaq
Gold polymerase (Perkin Elmer). PCR reactions of 50 cycles were
performed using primers that amplify a 184 bp DNA fragment from
Gab1β cDNA (GGACCATTCGAGGTGGCAGAC; CAACCCAGCATCA-
ACTTGCTGAC) or a 939 bp DNA fragment from β-actin cDNA (GTGA-
CGAGGCCCAGAGCAAGAG; AGGGGCCGGACTCATCGTACTC).
Disruption of Gab1β expression by homologous recombination
Genomic DNA spanning the Gab1β exon was obtained by screening the
RPC121 Mouse PAC library obtained from UK HGMP Resource Centre
(Osoegawa et al., 2000) with the 32P end-labelled Gab1β oligonucleotide
TACTCAGGTGTCATGCGTCTGCCACCTCGAATGGT. A ∼7 kb XbaI
DNA fragment encompassing the Gab1β exon was isolated from the PAC
clone 340-d21, cloned into pBS and sequenced using the Genome Priming
System (New England Biolabs). ET-cloning using bacterial recombination
was used to introduce a kanamycin gene into the Gab1β exon to create a
unique BamHI site into which a PGK polyadenylation signal was cloned
(Muyrers et al., 1999). This sequence was amplified with a 5′ primer
incorporating BamHI and SalI restriction sites and 3′ primer containing a
BglII site. Hygromycin, and blasticidin selection markers were then
individually cloned as BamHI, SalI fragments immediately upstream of
the PGK sequence to generate two targeting vectors. Plasmid was digested
with XbaI, to free the targeting vector from the plasmid backbone, prior to
transfections. In transfections, either 1×108 ESCs were electroporated
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(800V, 3 µF) with 150 µg linearised plasmid or 1×107 cells were
electroporated (240V, 500 µF) with 40 µg linearised plasmid. Cells were
plated at 2-3×106 cells per 10 cm dish and 48 h later treated with medium
containing blasticidin (10 µg/ml), hygromicin (100 µg/ml) or G418
(200 µg/ml). After ∼10 days of selection, colonies were picked and
expanded for freezing and DNA analysis. Genomic DNA was prepared
from clones grown to confluency in 24-well plates using proteinase K
digestion followed by isopropanol precipitation. Approximately 1/5th of the
resuspended DNA was restricted with EcoRV, transferred to an uncharged
Nylon filter (Amersham) by Southern blotting and hybridised with DNA
probes, located either 5′ or 3′ of the targeting construct, generated by PCR
(5′ probe primers: 5′-AGAGTCCTGTTGTATGCCTGG-3′, 5′-CAAGTA-
CTCCTTACTGCCCAG-3′; 3′ probe primers: 5′-GACTCACCAGAAAT-
GGGGTTC-3′, 5′-AGGTGATGTGGTTTCATGTAG-3′).
ESC self-renewal assays
To compare stem cell self-renewal between wild-type and Gab1 mutant
IOUD2 cells, Oct4-β-galactosidase activity was quantified as described
previously (Burdon et al., 1999). ESCs were plated in 24-well plates (5000
cells/well), cultured for 6 days and β-galactosidase activity in lysates was
measured using the ortho-nitrophenyl-β-galactoside (ONPG) assay. Specific
enzyme activity was normalised relative to the protein concentration of
lysates and standardised against a serial dilution of purified β-galactosidase
enzyme (Promega). Triplicate samples were assayed as duplicates.
Alkaline phosphatase activity was assayed in ESC lysates prepared from
cells in 24-well plates (described above), using 1 ml of 1 mMMgCl2, 0.2%
NP-40 per well and incubated for 2 h at 37°C. Duplicate aliquots (80 µl)
were mixed with 10 µl glycine buffer (1 M glycine, 10 mM ZnCl2, 10 mM
MgCl2), and 10 ml of 100 mM p-nitrophenyl phosphate (Sigma),
incubated in a 96-well plate for 20-60 min and the absorbance was read
at 405 nm.
Cell growth and proliferation assay
Cells were plated onto uncoated tissue culture 96-well plates at 20,000 or
40,000 cells per well in 100 µl of growth medium, and cell growth was
assayed using the CyQuant Direct Cell Proliferation Assay (C35011
ThermoFisher Scientific) to measure live cell-associated DNA fluorescence.
Each sample, was assayed by addition of 100 µl of 2× detection reagent
(0.4 µl Direct DNA stain, 2 µl Direct Background suppressor diluted in
100 µl Opti-MEM ThermoFisher Scientific 11058021), incubated for 1 h at
37°C in the incubator and then read on Victor Multi Label Counter from the
bottom of plates with standard green filter at 508/527 nm excitation/
emission wavelengths. Each cell line sample or treatment was measured in a
minimum of four independent wells for each experiment.
Cell cycle analysis
Single cell suspensions of cells were fixed in 70% ethanol, rehydrated in
phosphate buffered saline for 30 min at 4°C, rinsed twice with PBS and then
incubated with 100 µg DNAse-free RNAse for 1 h at room temperature.
Propidium iodide (final concentration 50 µg/ml) was added to the cells for
10 min before flow analysis (Fortessa X-20, Becton Dickinson: 561 nm
laser, emission 610 nm). Data were acquired using FACSDiva software
(Becton Dickinson). The cytometer was set to linear fluorescence for
optimal resolution for DNA, and data collected for 50,000 events per
sample. The percentages of G0, G1, S and G2 phases were manually
determined using FlowJo 10 software.
Apoptosis and cytotoxicity assays
Single-cell suspensions containing 1×105 cells/sample, as well as apoptosis
control treated with Staurosporine (1 µM, 1 h) and dead cell control (2%
DMSO, 1 h) were stained using the Annexin V–APC Kit (Biolegend)
according to the manufacturer’s instructions. Cells were washed once with
Annexin V Binding buffer, then resuspended in 100 µl of the same buffer
and stained using 5 µl Annexin V reagent. Samples were incubated for
15 min in the dark and then diluted with 400 µl binding buffer and adjusted
to 50 mg/ml propidium iodide, prior to flow analysis on a Fortessa
cytometer (Becton Dickinson: 640 nm laser, emission 670 nm). Data
analysis was carried out using FlowJo 10 software.
For assessing Apoptosis/Cytotoxicity/Viability we used the ApoTox-
Glow Triplex Assay (Promega G6320) according to the manufacturer’s
instructions. Cells were plated at 40,000 cells in 100 µl medium, per well of
tissue culture 96-well plates and grown for a further 2 days. The viability/
cytotoxicity reagent (20 µl) was added to each well, mixed by orbital
shaking and incubated for 30 min at 37°C and then read at 405 nm
(excitation)/505 nm (emission) for viability, and 485 nm (excitation)/
520 nm (emission) using a BioTek Synergy Ht plate reader. To measure
apoptosis, Caspase-Glo reagent (100 ml) was added to each well, mixed by
orbital shaking, incubated at room temperature for 30 min and the
luminescence was read using the Biotek Synergy Ht plate reader. Cells
treated with ethanol (0.7%, 1 h) and staurosporine (1 mM, 1 h) served as cell
death and apoptosis controls, respectively.
Northern analysis of RNA
RNA was prepared from cells lysed in acid guanidinium hydrochloride
(Chomczynski and Sacchi, 1987). Northern blots were produced
from samples containing 10 µg of total RNA probed with the 32P-labelled
Gab1α cDNA.
Quantitative reverse transcriptase PCR
RNA (1 µg) purified using RNeasy Mini Kit (Qiagen) was used to sythesise
cDNA using SuperScript First-Strand Synthesis System (Invitrogen).
Approximately 1/60th of the cDNA was amplified using Platinum SYBR
Green QPCR kit (Invitrogen) using the conditions; 50°C for 2 min, 95°C for
2 min followed by 40 cycles of 95°C for 15 s, 60°C for 30 s, with a final
cycle consisting of 95°C for 1 min, 60°C for 30 s and 95°C for 15 s.
Gab1 isoform-specific forward primers were: α, 5′-GGAGAAGAAGTT-
GAAGCGTTA-3′ and β, 5′-GACGCATGACACCTGAGTA-3′. The common
reverse primer was: 5′-GCAACACAAACCACCTTCT-3′. β-actin control
primers were: forward 5′-TGACAGGATGCAGAAGGAGA-3′, reverse
5′-GTACTTGCGCTCAGGAGGAG-3′.
Immunoprecipitation and immunoblotting
Immunoprecipitations were performed essentially as described previously
(Burdon et al., 1999). ESC (5×106) were plated overnight in 10-cm-diameter
dishes. The cells were serum and cytokine starved for 24 h prior to induction
with growth factors. Cells were lysed in 0.6 ml ice-cold lysis buffer
(150 mM NaCl, 10 mM Tris-HCl, pH 7.4, 0.5% NP40, 1 mM NaVO4,
1 mM EDTA, 0.5 mM PMSF), cleared of nuclear and cytoplasmic debris
and then incubated with∼1 µg antibody and Protein-A Sepharose for 4-16 h
at 4°C. Immune complexes were washed extensively and then boiled in SDS
sample buffer prior to gel electrophoresis. For protein analysis in whole cell
lysates, ESCs were plated at 5×106 cells per well in 6-well dishes. After
plating overnight and incubation for a further 24 h in serum-free medium,
cells were stimulated with growth factors, washed once with PBS and lysed
in 100 or 200 µl of SDS sample buffer. These lysates were sonicated and
boiled prior to loading on gels. Following electrophoresis on 8 or 10%
denaturing SDS-polyacrylamide gels, proteins were electroblotted onto
ECL-nitrocellulose filters (Amersham) and probed with antibodies (diluted
1:1000). The antibodies used in this study were obtained fromNew England
Biolabs/Cell Signalling Technology: phospho-Erk, #9101; phospho-Akt
(Ser473), #4058, phospho Gab1 Tyr307, #3234; phospho Gab1 Tyr627,
#3231; phospho Stat3, #9131, #9138; from BD/Transduction Labs: Erk2 ,
E16220; Stat3, S21320; Grb2, G16720; from Upstate Biotechnology:
phosphotyrosine, 4G10; Gab1 CT, #06-579; p85, #06-195; and from Santa
Cruz: SHP2, sc-280; Myc, sc-40; Oct4, sc-5279. A rabbit polyclonal
anti-Gab1 antibody was very generously provided by T. Hirano andM. Hibi
(Osaka University, Osaka, Japan) (Takahashi-Tezuka et al., 1998).
Immunocytochemistry and confocal microscopy
Approximately 1×106 cells in 500 µl of medium were allowed to attach to
glass coverslips (pretreated with 1% gelatin) in the bottom of a 6-well
culture dish for 1 h. Wells were then flooded with medium and the cells
cultured overnight. Cells on the cover slips were fixed for 10 min in 4%
paraformaldehyde at room temperature, gently washed five times with PBST
(PBS, 0.03% Triton X-100), and then incubated with blocking solution
(PBST, 3% goat serum, 1% BSA) for 1 h at room temperature. Primary
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antibodies were diluted in blocking solution and applied overnight at 4°C,
followed by four washes with PBST. Appropriate secondary antibodies were
diluted 1:1000 in blocking solution and applied for 1 h, at room temperature
in the dark. The cells were washed extensively with PBST, and the final
wash contained 10 µg/ml DAPI. The antibodies used were Oct4 primary
antibody at 1:200 (Santa Cruz, sc5279) with goat-anti-mouse IgG2b
secondary antibody, rabbit anti-Gab1 antibody at 1:500 (Takahashi-Tezuka
et al., 1998). The coverslips were then laid over the depression in a concave
microscope slide filled with 150 µl PBS and imaged using a Nikon EC1
confocal microscope at 60× magnification. For imaging live cells on
microscope slides, cells were maintained in Opti-MEM (Life Technologies).
3H palmitate labelling
Transfected cells were incubated for 4 h in medium containing 0.5mCi/ml
[3H]palmitic acid (Perkin Elmer) and 0.1% BSA (fatty acid free). The GFP-
tagged proteins were then immunoprecipitated with magnetic microbeads
coupled to GFP antibody (Miltenyi Biotech). Immunoprecipitated proteins
were separated by SDS-PAGE and transferred to nitrocellulose membranes.
[3H]palmitate present on the recovered GFP-tagged proteins was detected
using a Kodak Biomax Transcreen LE intensifier screen.
Statistical methods
Cell growth data were analysed using mixed models to allow for random
variability in the group effects occurring between the replicate experiments.
The models fitted: group, day and the group×day interaction as
fixed effects; and replicate, replicate×group, replicate×day and
replicate×group.day as random effects. A different residual variance was
allowed for each day of the trial, after checking that this led to a significant
improvement in the model compared with a model using a constant residual
variation, using a likelihood ratio test. In order to satisfy normality
assumptions, a log transformation of the data was used for all analyses
except that for Fig. 3B where a square root transformation was preferable.
Student’s t-tests were defined with the models to carry out pairwise
comparisons of specified groups on each day of the trial.
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